Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotaverine hydrochloride for shortening the first stage of labor in nulliparous women
PACTR201810902005232Phase 0Unknown
- Sponsor
- Ikeotuonye Arinze
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of drotaverine in childbirth (2 arms), sponsored by Ikeotuonye Arinze. Primary endpoint: Duration of first stage of labour. Status: unknown.
02
Drugs
drotaverine
03
Conditions
childbirth
Beyond the preview
Go deeper on PACTR201810902005232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810902005232.